Answers are grounded in this paper and cite their sources.
There is an increasing need to prescribe biosimilars to fund new medicines and increasing medicine volumes. Bertolani and Jommi document successful measures introduced regionally in Italy.
No takes yet. Share an insight, caveat, or question.
Godman et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: